RECTUM CANCER
Clinical trials for RECTUM CANCER explained in plain language.
Never miss a new study
Get alerted when new RECTUM CANCER trials appear
Sign up with your email to follow new studies for RECTUM CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to stall hard-to-treat colon cancer
Disease control OngoingThis study tests a two-drug combination (cabozantinib and nivolumab) in people with advanced colorectal cancer that is microsatellite stable (MSS) and has stopped responding to standard treatments. The goal is to see if the combination can control the cancer for at least 16 weeks…
Matched conditions: RECTUM CANCER
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated May 26, 2026 03:11 UTC
-
Donor NK cells aim to boost cancer fight in new trial
Disease control TerminatedThis early-phase study tests whether giving healthy donor natural killer (NK) cells along with two drugs (vactosertib and IL-2) is safe and helps the cells stay active in people with advanced colorectal, stomach/esophageal, or blood cancers. The NK cells are meant to attack cance…
Matched conditions: RECTUM CANCER
Phase: PHASE1 • Sponsor: David Wald • Aim: Disease control
Last updated May 26, 2026 03:09 UTC